Attached files
file | filename |
---|---|
EX-99.4 - EX-99.4 - WebMD Health Corp. | g21057exv99w4.htm |
EX-99.1 - EX-99.1 - WebMD Health Corp. | g21057exv99w1.htm |
EX-99.2 - EX-99.2 - WebMD Health Corp. | g21057exv99w2.htm |
EX-99.5 - EX-99.5 - WebMD Health Corp. | g21057exv99w5.htm |
EX-99.3 - EX-99.3 - WebMD Health Corp. | g21057exv99w3.htm |
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
November 3, 2009
Date
of Report (Date of earliest event reported)
WEBMD HEALTH CORP.
(Exact name of registrant as specified in its charter)
Delaware | 0-51547 | 20-2783228 | ||
(State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer Identification | ||
incorporation) | No.) |
111 Eighth Avenue
New York, New York 10011
New York, New York 10011
(Address of principal executive offices, including zip code)
(212) 624-3700
(Registrants telephone number, including area code)
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Table of Contents
Item 2.02. Results of Operations and Financial Condition
On November 3, 2009, WebMD Health Corp. issued a press release announcing its results for the
quarter ended September 30, 2009. A copy of the press release is attached as Exhibit 99.1 to this
Current Report. Exhibit 99.2 to this Current Report contains the financial tables that accompanied
the press release. Exhibit 99.4 to this Current Report contains an Annex to the press release
entitled Explanation of Non-GAAP Financial Measures and is also Annex to Exhibit 99.5 (described
below). Exhibits 99.1, 99.2 and 99.4 are being furnished and shall not be deemed filed for
purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act), nor shall any
of those exhibits be deemed incorporated by reference in any filing under the Securities Act of
1933 (the Securities Act) or the Exchange Act, except as shall be expressly set forth by specific
reference in such filing.
As previously disclosed, the merger of HLTH Corporation and WebMD (the Merger) was completed
on October 23, 2009. The Merger constitutes a reverse merger for accounting purposes, with HLTH
being treated as the acquiror. Accordingly, the pre-acquisition consolidated financial statements
of HLTH will be treated as the historical financial statements of WebMD going forward and will be
included in WebMDs Annual Report on Form 10-K for the year ending December 31, 2009. However,
since the Merger was completed after the end of the third quarter, the financial statements in
WebMDs Quarterly Report on Form 10-Q for that quarter will relate only to WebMD and WebMDs
historical financial statements will be the historical financial statements for purposes of that
filing.
Financial tables reporting HLTHs results for the quarter ended September 30, 2009 are
attached as Exhibit 99.5 to this Current Report. Exhibit 99.5 is being furnished and shall not
be deemed filed for purposes of Section 18 of the Exchange Act, nor shall it be deemed
incorporated by reference in any filing under the Securities Act or the Exchange Act, except as
shall be expressly set forth by specific reference in such filing. WebMD intends to file the
unaudited consolidated financial statements of HLTH for the three- and nine-month periods ended
September 30, 2009 and September 30, 2008 as an amendment to the Current Report on Form 8-K filed
by WebMD on October 26, 2009 regarding completion of the Merger.
2
Table of Contents
Item 7.01. Regulation FD Disclosure
Exhibit 99.3 to this Current Report includes forward-looking financial information that
accompanied Exhibit 99.1. Exhibit 99.3 is being furnished and shall not be deemed filed for
purposes of Section 18 of the Exchange Act, nor shall it be deemed incorporated by reference in any
filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by
specific reference in such filing.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits. The following exhibits are furnished herewith:
Exhibit | ||
Number | Description | |
99.1
|
Press Release, dated November 3, 2009, regarding the Registrants results for the quarter ended September 30, 2009 | |
99.2
|
Financial Tables accompanying Exhibit 99.1 | |
99.3
|
Financial Guidance Summary accompanying Exhibit 99.1 | |
99.4
|
Annex A to Exhibits 99.1 through 99.3 and to Exhibit 99.5 | |
99.5
|
Financial Tables regarding HLTH Corporations results for the quarter ended September 30, 2009 |
3
Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
WEBMD HEALTH CORP. |
||||
Dated: November 3, 2009 | By: | /s/ Lewis H. Leicher | ||
Lewis H. Leicher | ||||
Senior Vice President | ||||
4
Table of Contents
EXHIBIT INDEX
Exhibit | ||
Number | Description | |
99.1
|
Press Release, dated November 3, 2009, regarding the Registrants results for the quarter ended September 30, 2009 | |
99.2
|
Financial Tables accompanying Exhibit 99.1 | |
99.3
|
Financial Guidance Summary accompanying Exhibit 99.1 | |
99.4
|
Annex A to Exhibits 99.1 through 99.3 and to Exhibit 99.5 | |
99.5
|
Financial Tables regarding HLTH Corporations results for the quarter ended September 30, 2009 |